General Information of the Compound
| Compound ID |
CP0511742
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[2-[4-(5-fluoropyridin-2-yl)pyrazol-1-yl]ethyl]-5-methyl-2-(triazol-2-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H18FN7O
|
||||||||||||||||||
| Molecular Weight |
391.41
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(c(c1)C(=O)NCCn1cc(cn1)-c1ccc(F)cn1)-n1nccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H18FN7O/c1-14-2-5-19(28-24-6-7-25-28)17(10-14)20(29)22-8-9-27-13-15(11-26-27)18-4-3-16(21)12-23-18/h2-7,10-13H,8-9H2,1H3,(H,22,29)
Show/Hide
|
||||||||||||||||||
| InChIKey |
IIOKTGYGYMXVDL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1